BioCentury
ARTICLE | Clinical News

MammaPrint FFPE regulatory update

March 9, 2015 7:00 AM UTC

FDA granted 510(k) clearance to Agendia’s MammaPrint FFPE test to predict the risk of breast cancer recurrence in formalin-fixed paraffin embedded (FFPE) tissue. MammaPrint FFPE uses a 70-gene signatu...